Michigan Medicine and MedImmune, the global biologics research and development arm of AstraZeneca (NYSE: AZN), have entered into a three-year research alliance to identify potential new therapies for the prevention and treatment of diabetes, obesity and related metabolic disorders.
As part of the Cancer Moonshot, representatives from government, academic, pharmaceutical and diagnostic companies are launching a new partnership in pursuit of creating an open database for liquid biopsies to potentially accelerate the development of safe and effective blood profiling diagnostic technologies for patient benefit.
The University of Michigan Comprehensive Cancer Center is one of 12 sites to joinPrecision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
People with diabetes who rely on insulin have seen the cost of that drug triple in just a decade -- even as doctors have prescribed higher doses to drive down their blood sugar levels. Meanwhile, the cost of other diabetes drugs has stayed about the same or even gone down.
Each of your kidneys wears a little yellow cap that helps keep your blood pressure in check, and much more. But in some people, it starts running amok, pumping out a hormone that sends blood pressure sky-high. Why this happens is still a mystery. But new U-M findings could help figure out what’s going on.
It started out as a treatment for arthritis. But steered by science, it could become a first new approach in two decades for treating the damage that diabetes inflicts on the kidneys of millions of people.
Day in and day out, for years on end, millions of people with diabetes prick their fingers to test their blood sugar level. And many may wonder if all the careful eating, exercise and medication it takes to keep those levels under control is really worth it. A major new study should encourage them to keep going for the long haul.
Screening to identify Type 2 diabetes followed by early treatment could result in substantial health benefits, according to new research that combined large scale clinical observations and innovative computer modelling.
How can we keep more people from joining the ranks of the 29 million Americans already diagnosed with diabetes? What if we could tell with precision who has the highest risk of developing the disease, and figure out which preventive steps are most likely to help each of them individually? Researchers have just released a “precision medicine” approach to diabetes prevention that could do just that – using existing information, and without needing new genetic tests.
A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.
Research program will investigate an exciting new hypothesis about lost beta cell function in type 1 diabetes that may change our basic understanding of the disease and lead to novel prevention and restoration therapies.
Anyone who has seen a young relative cope with a new diagnosis of type 1 diabetes – or an adult relative handle the daily demands of the lifelong illness – knows what a toll it can take. Now, it’s even easier than ever for relatives of type 1 diabetes patients to help U-M researchers in the search for ways to prevent or delay the disease.
Two different genetic mutations cooperate to induce adrenal cancer, according to a new study. The finding provides new clues to this rare and deadly cancer type, and researchers hope it will lead to better treatments.
Researchers at the University of Michigan Kellogg Eye Center have identified a compound that could interrupt the chain of events that cause damage to the retina in diabetic retinopathy. The finding is significant because it could lead to a novel therapy that targets two mechanisms at the root of the disease: inflammation and the weakening of the blood barrier that protects the retina.
The University of Michigan's C.S. Mott Children's Hospital is among the best children's hospitals and is the only hospital in Michigan ranked in all 10 specialties evaluated, according to the U.S. News & World Report's 2012-13 Best Children's Hospitals rankings.